About Bioline  All Journals  Testimonials  Membership  News

Rwanda Medical Journal
Rwanda Health Communication Center - Rwanda Biomedical Center (RHCC - RBC)
ISSN: 2079-097X
EISSN: 2079-097X
Vol. 74, No. 4, 2017, pp. 6-8
Bioline Code: rw17020
Full paper language: English
Document type: Case Report
Document available free of charge

Rwanda Medical Journal, Vol. 74, No. 4, 2017, pp. 6-8

 en Cardio-respiratory complications in patients receiving Chloramphenicol in Rwanda: A case series
Sibomana, J. P.; Musabeyezu, E. & Donald, S.


In low-resource settings, antibiotic policy is complicated by the constraints of multiple drug resistance and by lack of affordability for patents [1]. Chloramphenicol remains widely used in these settings as an effective treatment for a range of serious infections [2], [3]. Important serious adverse effects of chloramphenicol include bone marrow suppression and ‘grey baby’ syndrome [4]. We report here three cases in which chloramphenicol treatment was associated with severe acute systemic cardio-respiratory complications within the space of 6 months of each other.

Chloramphenicol; Anti-bacterial agents; Drug-Related Side Effects; Adverse Reactions; Developing Countries

© Copyright 2017 - Rwanda Medical Journal
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil